ArticleFrontiers in artificial intelligence2026
An efficient multiplier-based FPGA CNN accelerator for Parkinson's disease detection using hand-drawn circle images.
Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study presents a Field-Programmable Gate Array (FPGA)-based convolutional neural network (CNN) accelerator for preliminary Parkinson's disease (PD) handwriting classification using hand-drawn circle images, with emphasis on arithmetic-level optimization through efficient multiplier architectures. Although optimized multipliers have been extensively studied for machine learning acceleration, their application-specific effects on inference consistency and hardware efficiency in healthcare-oriented FPGA implementations remain underexplored. Methods: To address this issue, a lightweight binary CNN classifier, trained on Google Colab, is deployed on FPGA hardware and evaluated with three multiplier architectures: standard multipliers, approximate logarithmic multipliers, and Karatsuba multipliers. The desktop CNN model was evaluated using both non-augmentation validation and standard augmentation strategies. The primary evaluation methodology used a non-augmentation validation approach, in which augmentation was applied exclusively to the training set, resulting in a software validation accuracy of 92.86%. The standard augmentation strategy achieved a validation accuracy of 97.83% and was used to compare the effects of augmentation before splitting. The trained model was quantized to Q4.12 fixed-point precision and implemented on FPGA hardware, where dense-layer computations were performed using different multiplier architectures. Hardware inference was validated on the NewHandPD hand-drawn circle dataset, and FPGA outputs were compared with software inference results via graphical analysis and Mean Absolute Deviation (MAD) to assess numerical consistency. Results: Experimental results indicate that the FPGA-based implementation achieved classification behavior closely aligned with software inference while improving hardware efficiency. Under the non-augmentation validation approach, the FPGA implementation achieved 89.73% accuracy compared to 92.86% in software, whereas the standard augmentation strategy achieved 95.40% accuracy compared to 97.83% in software using the Approximate Logarithmic Multiplier. Discussion: The results indicate the potential feasibility of lightweight CNN deployment with optimized multipliers for resource-efficient edge healthcare applications. However, due to the limited dataset size, the presented findings should be interpreted as a preliminary proof-of-concept study rather than definitive clinical validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.